Breaking News

CRO Charnwood Molecular Expands Capabilities

$75m construction project in Loughborough creates flexible facility for the growing CRO.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Loughborough’s life sciences hub Charnwood Campus has recommissioned its world-class synthetic and chemistry research facility to the highest standard to cater to the needs of its newest occupier and pre-clinical discovery contract research organization (CRO) Charnwood Molecular, in a  $75 million (£54m) construction project.   The three-story, state-of-the-art synthetic and chemistry research facility has been fully modernized by engineering firm Couch Perry Wilkes, following the delivery of a ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters